Hepatitis c and liver transplantation

Research output: Book/ReportBook

Abstract

This book provides a single reference for all transplant professionals involved in the care of HCV patients who have unique problems not encountered in other liver transplant patients. In the liver transplant community, it is well-known that decompensated cirrhosis from hepatitis C virus (HCV) is the leading indication for orthotopic liver transplantation (OLT) in the United States and most Western countries. Short-term results which initially seemed promising and comparable to other carefully selected liver transplant recipients now appear less encouraging with cirrhosis developing in 10-25% of patients by 5 years. Despite these concerns, there is an increased amount of data which supports re-transplantation in carefully selected patients.

Original languageEnglish (US)
PublisherNova Science Publishers, Inc.
Number of pages273
ISBN (Electronic)9781617611346
ISBN (Print)9781617286162
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Liver Transplantation
Hepatitis
Transplants
Hepacivirus
Liver
Fibrosis
Transplantation

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Mukherjee, S. (2010). Hepatitis c and liver transplantation. Nova Science Publishers, Inc.

Hepatitis c and liver transplantation. / Mukherjee, Sandeep.

Nova Science Publishers, Inc., 2010. 273 p.

Research output: Book/ReportBook

Mukherjee, S 2010, Hepatitis c and liver transplantation. Nova Science Publishers, Inc.
Mukherjee S. Hepatitis c and liver transplantation. Nova Science Publishers, Inc., 2010. 273 p.
Mukherjee, Sandeep. / Hepatitis c and liver transplantation. Nova Science Publishers, Inc., 2010. 273 p.
@book{61f1ced581c749f88afcafc9654e683a,
title = "Hepatitis c and liver transplantation",
abstract = "This book provides a single reference for all transplant professionals involved in the care of HCV patients who have unique problems not encountered in other liver transplant patients. In the liver transplant community, it is well-known that decompensated cirrhosis from hepatitis C virus (HCV) is the leading indication for orthotopic liver transplantation (OLT) in the United States and most Western countries. Short-term results which initially seemed promising and comparable to other carefully selected liver transplant recipients now appear less encouraging with cirrhosis developing in 10-25{\%} of patients by 5 years. Despite these concerns, there is an increased amount of data which supports re-transplantation in carefully selected patients.",
author = "Sandeep Mukherjee",
year = "2010",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781617286162",
publisher = "Nova Science Publishers, Inc.",

}

TY - BOOK

T1 - Hepatitis c and liver transplantation

AU - Mukherjee, Sandeep

PY - 2010/1/1

Y1 - 2010/1/1

N2 - This book provides a single reference for all transplant professionals involved in the care of HCV patients who have unique problems not encountered in other liver transplant patients. In the liver transplant community, it is well-known that decompensated cirrhosis from hepatitis C virus (HCV) is the leading indication for orthotopic liver transplantation (OLT) in the United States and most Western countries. Short-term results which initially seemed promising and comparable to other carefully selected liver transplant recipients now appear less encouraging with cirrhosis developing in 10-25% of patients by 5 years. Despite these concerns, there is an increased amount of data which supports re-transplantation in carefully selected patients.

AB - This book provides a single reference for all transplant professionals involved in the care of HCV patients who have unique problems not encountered in other liver transplant patients. In the liver transplant community, it is well-known that decompensated cirrhosis from hepatitis C virus (HCV) is the leading indication for orthotopic liver transplantation (OLT) in the United States and most Western countries. Short-term results which initially seemed promising and comparable to other carefully selected liver transplant recipients now appear less encouraging with cirrhosis developing in 10-25% of patients by 5 years. Despite these concerns, there is an increased amount of data which supports re-transplantation in carefully selected patients.

UR - http://www.scopus.com/inward/record.url?scp=85026505794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026505794&partnerID=8YFLogxK

M3 - Book

AN - SCOPUS:85026505794

SN - 9781617286162

BT - Hepatitis c and liver transplantation

PB - Nova Science Publishers, Inc.

ER -